Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07033897 · ClinicalTrials.gov registry record · NA
Adapting, Implementing and Evaluating the Effectiveness of HARP for People With Disabilities
A NA study of Falls and Fall Prevention, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT07033897: Recruiting NA study of Falls and Fall Prevention, sponsored by Washington University School of Medicine.
NCT07033897 is a NA study of Falls and Fall Prevention that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 80 participants, below the 219-participant average among 7 other Falls trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07033897, a NA study of Falls and Fall Prevention, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The Home Hazard Removal Program (HARP) is an effective fall prevention intervention program which targets home hazard identification/removal. In this study the investigators will examine the effectiveness and implementation potential of HARP, adapted for PwD. Investigators will conduct a pilot randomized control trial (RCT) to test the implementation, cost, and preliminary efficacy of an adapted version of HARP for community-dwelling PwD. The single-blinded feasibility RCT will randomize 40 participants to treatment (adapted HARP) and 40 to a waitlist control group. Data on specific types of fall hazards and resulting home modifications as well as falls and fall-related injuries (collected monthly over 12 months) and fear of falling (collected at baseline and 12 months) will inform the preliminary efficacy of adapted HARP among PwD. To ensure usefulness, relevance, and broad dissemination of findings, the investigators will adopt a "designing for implementation and dissemination" approach. The RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework will guide intervention adaptation, trial design, and future implementation. The Practical Robust Implementation and Sustainability Model (PRISM) guides study development by identifying multi-level contextual factors hypothesized to affect the RE-AIM outcomes.
Primary Outcome
Reduction in fall rates
Conditions Studied
Interventions
- BEHAVIORAL Adapted HARP
Study Locations (1)
Missouri
- Washington University in St. Louis - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-08-20 |
| Est. Completion | 2028-03-14 |
| Phase | NA |
What NCT07033897 shows while recruiting
NCT07033897 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 219-participant average among 7 other Falls trials with a reported enrollment target (63% lower).
The record links to 4 conditions, with Falls appearing as the primary indexed condition, and to 1 intervention - of which Adapted HARP is the first listed.
NCT07033897 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT07033897 about?
NCT07033897 is a clinical study titled "Adapting, Implementing and Evaluating the Effectiveness of HARP for People With Disabilities". The Home Hazard Removal Program (HARP) is an effective fall prevention intervention program which targets home hazard identification/removal. In this study the investigators will examine the effectiveness and implementation potential of HARP, adapted for PwD. Investigators will conduct a pilot rando...
What is the current status of trial NCT07033897?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-08-20. Estimated completion is 2028-03-14.
What conditions does trial NCT07033897 study?
This clinical trial studies the following conditions: Falls, Fall Prevention, Adults, Disabilities Physical.
What interventions are being tested in trial NCT07033897?
The interventions under investigation include: Adapted HARP (BEHAVIORAL).
Who is sponsoring clinical trial NCT07033897?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07033897 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Falls
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reducing Fall Risk With NMES
ACTIVE NOT RECRUITING · NA
-
Orthostatic Hypotension Treatment on Rehab Unit
COMPLETED · NA
-
A Pilot Study of the Impact of Vitamin D3 on Muscle Performance in Elderly Women
COMPLETED · NA
-
Wii-fit for Activity, Balance and Gait in Assisted Living
COMPLETED · NA
-
How's Your Balance?
ACTIVE NOT RECRUITING
-
Preliminary Clinical Trial- FallScape-D
ACTIVE NOT RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI